ERbiosys.com is a precision oncology bioinformatics startup that focuses on research and development of an affordable genetic breast cancer test to advise women on an optimal treatment. To identify patterns leading to precise treatment recommendations we use our proprietary AI technology.
The company has a special focus on:
- identification of cancer signaling pathways based on multi-omics molecular information,
- evaluation of drug toxicity for a particular person,
- analysis of mechanisms of drug resistance,
- research of alternative cancer treatment options (based on evidence gathered from stage 4 survivors),
- providing recommendations by referencing NCCN and ESMO guidelines, clinical trials, PubMed, and other academic research publications.
Company Details
- Employees
- 2
- Founded
- -
- Address
- Vilnius, 06335, Lt
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.erbiosys.com
- Keywords
- XpanMed.
- HQ
- Vilnius
Erbiosys Questions
Erbiosys's website is http://www.erbiosys.com
Erbiosys's LinkedIn profile is https://lt.linkedin.com/company/erbiosys
Erbiosys has
2 employees.
View email and phone details for 2
employees at Erbiosys.
Erbiosys's industry is
Biotechnology Research
Erbiosys's top competitors are
Techface,
Xpanmed,
Proteina Limited,
Alpine-Bio,
Urbanitor,
Clonosapiens,
Geoportal.lt,
Optimal Pims Pharmatech Solution Inc.,
Hnit-Baltic,
Dating Stars.
Erbiosys's categories are Biotechnology Research
Erbiosys's founding year is 2024
